Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists: a pan-European survey

Bone Marrow Transplantation volume 58, pages 829–831 (2023)Cite this article

Subjects

Interdisciplinary collaboration between physicians and clinical pharmacists and pharmacologists makes an important contribution to optimising drug therapy in hospitals. This is particularly essential for patients receiving complex therapies with high-risk medications. In the USA, recommendations have been published by different societies to ensure that clinical pharmacists possess the knowledge, skills, attitudes, and behaviours necessary to deliver comprehensive medication management (CMM) in team-based, direct patient care environments [1, 2]. For the European region, the EBMT Pharmacist Committee recently published consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation (HSCT) and cellular therapies [3].

As a way of benchmarking service provision and to support appropriate targeting of educational initiatives in this area, the EBMT Pharmacist Committee decided to undertake a survey of pharmacy services within EBMT transplant centres.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Pharmacist/pharmacologist activities.

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author upon reasonable request.

References

  1. Saseen JJ, Ripley TL, Bondi D, Burke JM, Cohen LJ, McBane S, et al. ACCP clinical pharmacist competencies. Pharmacotherapy. 2017;5:630–36.

    Article  Google Scholar 

  2. Clemmons AB, Alexander M, DeGregory K, Kennedy L. The hematopoietic cell transplant pharmacist: roles, responsibilities, and recommendations from the ASBMT Pharmacy Special Interest Group. Biol Blood Marrow Transpl. 2018;5:914–22.

    Article  Google Scholar 

  3. Langebrake C, Admiraal R, van Maarseveen E, Bonnin A, Bauters T, Group EW. Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation. Bone Marrow Transpl. 2020;1:62–9.

    Article  Google Scholar 

  4. Faraci M, Lorenzi I, Martino M, Mammoliti S, Lurilli V, Serra N, et al. The role of pharmacies in haematopoietic stem cell transplantation process: a nationwide survey by Gruppo Italiano Trapianto di Midollo Osseo. J Clin Pharm Ther. 2021;46:1665–79.

    Article  PubMed  Google Scholar 

  5. Barboza-Zanetti MO, Barboza-Zanetti AC, Rodrigues-Abjaude SA, Pinto-Simões B, Leira-Pereira LR. Clinical pharmacists’ contributions to hematopoietic stem cell transplantation: a systematic review. J Oncol Pharm Pract. 2019;25:423–33.

    Article  PubMed  Google Scholar 

  6. Gawedzki P, Collins J. Impact of the implementation of a pharmacist-driven immunosuppression drug monitoring protocol for hematopoietic stem cell transplant recipients. J Oncol Pharm Pract. 2021;27:1907–13.

    Article  CAS  PubMed  Google Scholar 

  7. Polito S, Ho L, Pang I, Dara C, Viswabandya A. Evaluation of a patient self-medication program in allogeneic hematopoietic stem cell transplantation. J Oncol Pharm Pract. 2022;28:1790–7.

    Article  PubMed  Google Scholar 

  8. European Association of Hospital Pharmacists. EAHP Position Paper on Advanced Therapy Medicinal Products. 2022. eahp_position_paper_on_advanced_therapy_medicinal_products.pdf. Accessed 13 Dec 2022.

  9. British Oncology Pharmacy Association. BOPA Medicines Optimisation, Safety and Clinical Pharmacy workforce. 2015. https://www.bopa.org.uk/resources/bopa-medicines-optimisation-safety-and-clinical-pharmacy-workforce-plan-january-2015/. Accessed 13 Dec 2022.

  10. Ice LL, Bartoo GT, McCullough KB, Wolf RC, Dierkhising RA, Mara KC, et al. A prospective survey of outpatient medication adherence in adult allogeneic hematopoietic stem cell transplantation patients. Biol Blood Marrow Transpl. 2020;26:1627–34.

    Article  CAS  Google Scholar 

  11. Charra F, Philippe M, Herledan C, Caffin AG, Larbre V, Baudouin A, et al. Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: impact of a specialized clinical pharmacy program. J Oncol Pharm Pract. 2021. https://doi.org/10.1177/10781552211000115.

Download references

Author information

Authors and Affiliations

  1. Queen Elizabeth Hospital, Birmingham, UK

    Nick Duncan

  2. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

    Maria-Estela Moreno-Martinez

  3. School of Health Sciences Blanquerna, University Ramon Lull, Barcelona, Spain

    Maria-Estela Moreno-Martinez

  4. Insituto Português de Oncologia de Lisboa, Lisbon, Portugal

    Vera Pires & Vera Domingos

  5. Assistance Publique – Hôpitaux de Paris, Paris, France

    Agnes Bonnin

  6. Oslo universitetssykehus, Oslo, Norway

    Katerina Nezvalova-Henriksen

  7. Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands

    Rick Admiraal

  8. Ghent University Hospital, Ghent, Belgium

    Tiene Bauters

  9. University Medical Centre Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany

    Claudia Langebrake

  10. University Medical Centre Hamburg-Eppendorf, Hospital Pharmacy, Hamburg, Germany

    Claudia Langebrake

Authors
  1. Nick Duncan
    View author publications

    Search author on:PubMed Google Scholar

  2. Maria-Estela Moreno-Martinez
    View author publications

    Search author on:PubMed Google Scholar

  3. Vera Pires
    View author publications

    Search author on:PubMed Google Scholar

  4. Vera Domingos
    View author publications

    Search author on:PubMed Google Scholar

  5. Agnes Bonnin
    View author publications

    Search author on:PubMed Google Scholar

  6. Katerina Nezvalova-Henriksen
    View author publications

    Search author on:PubMed Google Scholar

  7. Rick Admiraal
    View author publications

    Search author on:PubMed Google Scholar

  8. Tiene Bauters
    View author publications

    Search author on:PubMed Google Scholar

  9. Claudia Langebrake
    View author publications

    Search author on:PubMed Google Scholar

Consortia

for the Pharmacist Committee of the EBMT

Contributions

All authors contributed to the questionnaire design. ND and CL wrote the first draft of the manuscript. All authors provided critical feedback and contributed to the final manuscript.

Corresponding author

Correspondence to Nick Duncan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duncan, N., Moreno-Martinez, ME., Pires, V. et al. Role and competencies of the EBMT clinical pharmacists and clinical pharmacologists: a pan-European survey. Bone Marrow Transplant 58, 829–831 (2023). https://doi.org/10.1038/s41409-023-01983-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41409-023-01983-9

This article is cited by

Search

Advanced search

Quick links